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ABSTRACT: Solid-state NMR is becoming a viable alternative
for obtaining information about structures and dynamics of large
biomolecular complexes, including ones that are not accessible to
other high-resolution biophysical techniques. In this context,
methods for probing protein−protein interfaces at atomic
resolution are highly desirable. Solvent paramagnetic relaxation
enhancements (sPREs) proved to be a powerful method for
probing protein−protein interfaces in large complexes in solution
but have not been employed toward this goal in the solid state.
We demonstrate that 1H and 15N relaxation-based sPREs provide
a powerful tool for characterizing intermolecular interactions in
large assemblies in the solid state. We present approaches for
measuring sPREs in practically the entire range of magic angle spinning frequencies used for biomolecular studies and discuss
their beneﬁts and limitations. We validate the approach on crystalline GB1, with our experimental results in good agreement with
theoretical predictions. Finally, we use sPREs to characterize protein−protein interfaces in the GB1 complex with
immunoglobulin G (IgG). Our results suggest the potential existence of an additional binding site and provide new insights
into GB1:IgG complex structure that amend and revise the current model available from studies with IgG fragments. We
demonstrate sPREs as a practical, widely applicable, robust, and very sensitive technique for determining intermolecular
interaction interfaces in large biomolecular complexes in the solid state.
■ INTRODUCTION
Knowledge of protein−protein interactions is essential for the
understanding of many biological processes. However, atomic-
resolution structural characterization of many important
biomolecular complexes is impeded by their size, solubility,
or ability to form crystals, preventing the application of
standard methods such as solution NMR and X-ray
crystallography. Solid-state NMR is an emerging alternative
for studies of large protein assemblies,1−10 with new
technologies and methods leading to continuously improved
sensitivity and signal resolution for atomic-level structural
information on large protein complexes.
Paramagnetic relaxation enhancement (PRE) occurs when an
unpaired electron increases nuclear relaxation rates through
dipolar interactions, which depend on the distance between the
nucleus and the paramagnetic center. Strategies that make use
of paramagnetic molecules help to alleviate the challenge of low
sensitivity by enabling fast repetition of experiments and also
provide a source of information about structures and
dynamics.7,11−21 PREs have been used successfully in the
solid state with the PREs obtained from paramagnetic tags
attached to the proteins22 or by replacing non-paramagnetic
ions with paramagnetic ions in metalloproteins.11,16,23,24 One
potential disadvantage of such approaches is that introducing a
non-native moiety into the protein can inﬂuence its structural
integrity and/or dynamics, and such eﬀects have to be
considered carefully. In this context, employing an inert
paramagnetic molecule dissolved in the solvent and which
does not bind to the protein is less invasive and can provide
long-range structural information with less potential for
inﬂuencing the structure and dynamics of the studied
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system.25,26 If a paramagnetic compound, such as gadolinium
diethylenetriaminepentaacetic acid bismethylamide (Gd-
(DTPA-BMA)), is added to the buﬀer surrounding the protein,
the paramagnetic eﬀects from such an agent, often called
solvent PREs (sPREs), can be used to quantify solvent
accessibility.27−30 sPREs have been used in solution NMR to
gain additional restraints for structure calculation, prediction,
and validation,31−33 to probe domain architecture,34 and to
analyze protein−protein interactions.35
While paramagnetic agents are often used to speed up
acquisition in solid-state NMR,36 there are few examples where
sPREs have been used to study solvent accessibility in solid-
state NMR, and, to our knowledge, they have not yet been
employed for characterization of protein−protein interfaces in
biomolecular complexes. However, sPREs have been used, e.g.,
to identify crystal contacts in a heavily deuterated crystalline
sample of the α-spectrin domain of SH3.17 In that work,
irregularly high 1H sPREs for residues in close proximity to
exchangeable hydroxyl protons (<3.5 Å) were observed, leading
to major challenges in the interpretation of distances between
nuclei and protein surface.17 In another study, 13C R1-based
sPREs were used to identify regions with increased solvent
accessibility in Aβ1−40 ﬁbrils.
37 Because of still-active spin
diﬀusion, which leads to the partial averaging of 13C R1 rates
over several sites,38 the obtained sPREs were only qualitative in
nature.37 Overall, elimination of spin diﬀusion is a prerequisite
for obtaining quantitative site-speciﬁc sPREs. Suppression of
spin diﬀusion can be achieved through either dilution of the
strong dipolar proton−proton network through deuteration17
or fast magic angle spinning (MAS) or a combination of the
two approaches.39
Here, we explored sPREs derived from 1H R1,
15N R1, and
15N R1ρ measurements in order to develop a practical approach
for applying sPREs to characterize protein−protein interfaces in
large complexes in the solid state. We considered several factors
that can inﬂuence applicability of the approach, including
signal-to-noise ratio, site-speciﬁc nature of measurements,
sensitivity and dynamic range of the employed probe, and
accessibility of specialized equipment.
To test the suitability of solid-state sPREs to map solvent
accessibility, we have performed measurements on the B1
domain of immunoglobulin-binding protein G (GB1) in three
diﬀerent environments: isolated GB1 in solution (GB1free),
GB1 in a crystal on its own (GB1cryst), and ﬁnally, GB1 in a
precipitated complex with full-length IgG (GB1IgG). Protein G
produced by group G and C streptococcci40 is part of the
bacterial defense strategy against antibodies that enables the
bacteria to escape detection by the host immune system.41 The
high aﬃnity between GB1 and IgG is commonly exploited in
numerous biotechnological applications, such as immuno-
sorbent assays or aﬃnity puriﬁcation of antibodies. Insights
into molecular aspects of the complex can guide and support
therapeutic strategies as well as bioengineering eﬀorts. Diﬀer-
ences in the solvent accessibility from sPREs revealed details of
binding of GB1 to IgG and evidence for previously not
observed additional interactions.
■ RESULTS AND DISCUSSION
Overview of the Diﬀerent sPRE Approaches. In
solution NMR, sPREs can be obtained by measuring relaxation
rates in a sample with increasing concentration of a
paramagnetic dopant. The slope of the line obtained from
ﬁtting the relaxation rates as a function of dopant concentration
yields the sPREs. The same approach can be used in the solid
state, but with an individually prepared sample for each dopant
concentration. The most popular paramagnetic dopant used in
solid-state NMR applications is CuEDTA. However, complexes
using EDTA as a chelator were shown to bind preferentially to
some proteins due to their overall negative charge and thus
introduce undesired bias in sPRE applications.42,43 Even though
CuEDTA does not bind to either GB1 or GB1:IgG complex, in
order to increase general applicability of the approach, we have
decided to use a neutral probe for most of our measurements.
Toward this aim, we employed Gd(DTPA-BMA), which is one
of the most popular stable neutral paramagnetic probes for
sPRE applications in solution NMR and a popular intravenous
MRI contrast agent. An additional beneﬁt of using this dopant
instead of CuEDTA is that Gd3+ is much more eﬃcient in
inducing PREs compared to Cu2+, which means that much
smaller concentrations of the dopant can be used to obtain a
similar eﬀect.44 Reducing the required dopant concentration
aids, e.g., to minimize the rf induced heating.
We found that Gd(DTPA-BMA) can be added to hydrated
protein samples in solid-state NMR after they were prepared in
the required solid form, e.g., crystal, sediment, or precipitate,
without need for co-crystallization of the proteins with the
paramagnetic agent as it has been suggested previously.17 We
did not observe any signiﬁcant deviations from a linear
relationship between relaxation rates and dopant concen-
trations under the conditions and concentrations explored in
this study. The advantage in measuring sPREs with this
approach lies in the fact that the sPREs do not need to be
modeled explicitly (e.g., ﬁtting correlation times, etc.),
consequently allowing a more straightforward comparison
between sPREs derived from diﬀerent types of measurements
in solution and solid state. However, global scaling of the data is
required to allow comparison of two data sets (see below).
1H relaxation for sPRE in the solid state is one of the most
sensitive probes to paramagnetic eﬀects. For 1H relaxation
measurements, to maximize sensitivity, one would like to
maximize concentration of the protons in the sample.7,45,46,37,38
On the other hand, to suppress the rate-averaging spin
diﬀusion, one needs to minimize the concentration of protons
or average out the 1H−1H dipolar couplings by fast MAS. For
diﬀerent levels of protonation, diﬀerent spinning frequencies
are optimal. For example, deuterated 100% back-exchanged
samples at 60 kHz spinning provide the best compromise
between resolution and sensitivity.45 However, the 1H−1H spin
diﬀusion is not suﬃciently suppressed under these conditions
to enable site-speciﬁc measurements.47 Due to both cost and
practical considerations, we decided to use deuterated GB1
with 100% back-exchanged protons and fully protonated
natural abundance IgG. The presence of more protons in the
system required very fast spinning to suﬃciently suppress
1H−1H spin diﬀusion for site-speciﬁc measurements of 1H
sPREs (Figure 4a). We have previously demonstrated that high-
quality spectra can be obtained for 100% back-exchanged
[U-2H,13C,15N]GB1 in complex with natural abundance IgG
using as little as 15 μg of labeled protein in a 0.81 mm rotor
with ∼100 kHz MAS.7 Furthermore, recent studies report that,
at >100 kHz, spinning frequencies, 1H−1H spin diﬀusion is
signiﬁcantly slowed down even in fully protonated samples,
especially for protons with large diﬀerences in their chemical
shifts.47,48 This is in accordance with the observation of large
diﬀerences in site-speciﬁc 1H R1 (Figure 4a) in our experiments,
suggesting that, at 100 kHz spinning, 1H−1H spin diﬀusion is
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suﬃciently slowed downif not completely suppressedto at
least allow characterization of the protein−protein interfaces
from sPREs (e.g., T18H and E19H are separated by about 1
ppm, and their sPREs diﬀer by a factor of ∼2). The suﬃcient
suppression of the proton spin diﬀusion is corroborated by the
absence of the unusually high 1H sPREs for amide protons in
the proximity of hydroxyl sites that were observed in the
presence of residual spin diﬀusion17 (e.g., T18H, which one
might expect to be inﬂuenced in this way, has a rather low
sPRE).
Employing 1H’s for sPRE measurements will therefore
require specialized and still not widely available ultrafast MAS
probes. In addition, experiments at >100 kHz spinning
frequencies necessitate use of rotors with very small volumes.
The decrease of signal-to-noise ratio due to the small sample
volume can be, to a large extent, oﬀset by detecting signal on
protons.46 However, 100% back-exchanged perdeuterated
samples can be used eﬀectively for 1H-detected experiments
already at 60 kHz, in which case larger volume rotors can be
used.45 Finally, for systems with extensive slow dynamics,
sometimes adequate 1H resolution is diﬃcult to achieve, even at
the highest spinning frequencies, requiring use of 13C- or 15N-
detected experiments, in which case larger volume rotors are
desirable. For the above reasons, it is worth exploring other
probes for sPREs that can be utilized at slower spinning
frequencies in larger volume rotors.
In the case of 15N, at spinning frequencies >20 kHz, proton-
driven spin diﬀusion is suﬃciently slowed down to enable site-
speciﬁc measurements of 15N R1 even in fully protonated
systems.49−51,56 In the solid state, protein 15N T1’s are very long
(20−40 s), so, in spite of lower sensitivity of 15N to
paramagnetic eﬀects compared to 1H, a high dynamic range
of the relaxation rates is available, and relatively small changes
can be detected. Consequently, large variations in 15N sPREs
can be observed, just as in the case of 1H, but the
measurements can be performed even at moderate spinning
frequencies (as low as 10 kHz49−51 if minimal rate averaging
can be tolerated). A disadvantage of using 15N R1 for sPREs is
that the long relaxation times require long (i.e., many seconds)
relaxation delays for adequate sampling of the relaxation rates,
resulting in long overall experimental times. Alternatively, we
examined the applicability of the typically much shorter 15N T1ρ
times (on the order of dozens to hundreds of milli-
seconds9,10,52−55) as the basis for sPREs. Below we demonstrate
that 15N R1ρ sPREs are suﬃciently sensitive to characterize
protein−protein interfaces, with the emerging picture virtually
identical to the one obtained from 15N R1. The much shorter
required relaxation delays in 15N R1ρ experiments permit
considerably faster performance compared to 15N R1 sPRE
acquisition, further allowing higher signal-to-noise ratios in the
available experimental time. For example, measurements for
one concentration of paramagnetic dopant for GB1IgG took 3−
4 days in the case of 15N R1 (estimation of
15N R1 from only
two points, which took 5 days, was practically possible for the
diamagnetic variant with the measurement of a full curve being
prohibitively long8) and 18−24 h in the case of 15N R1ρ. As a
side note, 1H T1ρ typically is too short to provide a reliable
quantitative sPRE probe (or at least not in a range where no
signiﬁcant line broadening is observed).
sPREs: Solution vs Crystal. First, we set out to explore the
applicability of sPREs by investigating reduced solvent
accessibility in GB1 crystals. To that end, we used experimental
15N R1-based sPREs of free GB1 in solution (GB1free) to
provide a baseline for observing changes in solvent accessibility
due to protein−protein interactions and crystal contacts. The
15N R1-based sPREs shown in Figure 1a inform on the solvent
accessibility of the protein in the absence of intermolecular
interactions, and regions that are well protected from solvent
access in isolated GB1 can be identiﬁed as most of β1, parts of
the α-helix, and parts of β4. In contrast, the most accessible
regions are the outer beta strands β2 and β3. This is in good
agreement with scaled theoretical sPREs calculated from an
available structure of isolated GB1 using a previously described
grid-based approach30,33,56 (see Experimental Section). The
predicted values reproduce the experimental sPREs well, with
the exception of β2 and Y45, where sPREs are underestimated.
The discrepancy for β2 could potentially be explained by the
previously reported large-amplitude motions of the strand
involving rotations around its long axis, which render the amide
nitrogens more solvent accessible.57 We note that ultimately
conformational dynamics should be taken into account when
calculating sPREs from structures.
The 15N R1-based sPREs measured in GB1 crystals (GB1cryst)
present a quite diﬀerent picture (Figure 1b): in contrast to
GB1free, the outer β2 and β3 strands are much more protected
in the crystal compared to the most solvent accessible residues
in loop 1. This is consistent with the fact that, in crystals, GB1
forms extended β-sheets stabilized by intermolecular hydrogen
bonds between β2 and β3.59,60 Moreover, the scaled theoretical
15N sPREs calculated for GB1 in a lattice agree reasonably well
with the experimental sPREs except for T11 and T49, which
are located in the loops, and L6. In contrast to the previous
study on crystalline SH3,17 we do not observe the unexpectedly
high relaxation rates for sites in close proximity to hydroxyl
groups (unless these sites are solvent accessible, in which case
we do observe high PREs). Absence of this eﬀect in our
experiments suggests that the assumption of the absence of spin
diﬀusion in a perdeuterated sample with 10% back-exchanged
protons at moderate spinning frequency (24 kHz)17 might not
have been entirely justiﬁed. Residual spin diﬀusion due to
locally higher density of exchangeable protons and moderate
spinning frequency can easily explain the anomalously high
sPREs observed by Linser et al.17 Under conditions suggested
in the present work, proton-driven spin diﬀusion between
nitrogens is extremely well suppressed, which abolishes any
eﬀect of the exchangeable hydroxyl protons on the relaxation
rates of amide sites in the vicinity.
Theoretical sPREs can be used to validate models by
comparing the experimental sPREs to the ones predicted from
the model. However, even in the absence of a model,
intermolecular interactions can be detected by identifying
sites with increased protection from the solvent due to these
interactions. We propose to simply use the diﬀerence between
experimental sPREs in the absence and presence of
intermolecular interactions, i.e., for GB1 free in solution
(GB1free) and GB1 in the assembly (GB1cryst or GB1IgG in
the latter part of the paper), respectively. Remarkably, the
diﬀerence sPREs (ΔsPREs) provide a powerful way to detect
intermolecular interactions. In general, one will need to take
into account any conformational changes upon binding whose
eﬀect cannot be distinguished from reduced solvent accessi-
bility due to binding without additional data. GB1 does not
undergo any large backbone conformational changes either in
crystal or in the GB1:IgG complex,7,8,61 so no further
correction is required. In cases where secondary chemical
shifts indicate conformational changes upon binding, solving
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the structure of the considered protein in a complex will be
prerequisite for quantiﬁcation of the protein interface using
sPREs (though qualitative information about the interactions
still can be obtained in the absence of such a structure).
Because of the “built-in” compensation for solvent accessibility
patterns due to the conformation of the molecule, the eﬀect of
intermolecular interactions is eﬀectively “ampliﬁed” in ΔsPREs.
The potential of ΔsPREs is illustrated by the experimental
15N R1 ΔsPREs for GB1cryst shown in Figure 1c−e, which
highlight the increased protection of β2 and β3 due to the
presence of intermolecular hydrogen bonds in the crystal. At
the same time, other subtler features become apparent, such as
better protection of the N-terminus compared to the C-
terminus or slightly higher protection of the C-terminal end of
the helix compared to the N-terminal end. Note that to
minimize the bias and to account for the diﬀerent dynamic
ranges of the data sets that are subtracted to yield ΔsPREs, they
were scaled by a global factor equal to the ratio of the rate
averages of the two data sets (see the Experimental Section).
For visualization purposes, a constant (equal to the absolute
value of the minimum ΔsPREs) is added so that all
experimental ΔsPREs have the same sign.
sPREs in GB1:IgG Complex. Currently only structures of
protein G domains with immunoglobulin G (IgG) fragments
are available. Interactions between the Fab fragment of IgG and
protein G domains have been investigated by X-ray
crystallography62 and solution NMR.63 The crystal structure
showed that the main interactions between the Fab fragment
and GB3 correspond to residues 10−18 of GB1 and a minor
contact between the Fab fragment and residues 33 and 37 of
GB1 (for clarity we use GB1 residue numbering throughout
this paragraph). The solution NMR analysis identiﬁed chemical
shift perturbations (CSPs) in residues 9−17 (also 7, 19, 36, 37,
38, 40, 43, and 53).63 In solution NMR studies of GB2 and the
Fc fragment of IgG, residues in regions 23−36 and 40−46,
which are located in β3 and the α-helix of GB1, were found to
be involved in the interaction.64 This is in agreement with a
crystal structure of GB2 in complex with the Fc fragment of
IgG, where the residues involved in binding correspond to
residues 27, 28, 31, 32, 35, 40, 42, and 43 of GB1.65 It is worth
noting that residues involved in binding to the Fab fragment
(residues 9−18) were not aﬀected by the interaction with the
Fc fragment.65 In our previous solid-state NMR study of the
complex of GB1 bound to full-length human IgG, we
established that GB1 binds to both Fab and Fc fragments of
IgG simultaneously.7 Here we use the sPRE methodology
validated above on the GB1 crystal to obtain further insights
into the GB1-IgG interactions.
In the range explored by us, 15N R1 or R1ρ relaxation rates vs
Gd(DTPA-BMA) concentration in a precipitated GB1:IgG
complex show a good linear relationship (see Figure 2a,b and
Supporting Information (SI) Figure 3). The sPREs obtained
from slopes of such trends are shown in Figure 2c (15N R1
sPREs) and Figure 2d (15N R1ρ sPREs). A direct comparison of
predicted and experimental sPREs (SI Figure 1) shows that
interactions with both Fc and Fab fragments must be present.
To further analyze the increased protection due to protein−
protein interactions, we focus on ΔsPREs in the discussion. As
we mentioned above, this is preferred to direct analysis of
sPREs because ΔsPREs mostly suppress pattern of protection
from solvent due to conformation of the studied protein,
leaving one with a pattern mostly based on intermolecular
interactions (unless the protein undergoes signiﬁcant con-
Figure 1. Experimental 15N R1 solvent PREs for GB1 (a) in solution
and (b) in a crystal (b). (c) Experimental 15N R1 ΔsPREs for GB1
crystal (i.e., diﬀerence between, normalized to averages, 15N R1 sPREs
in solution and in crystal) as a function of residue, and (d,e) projected
onto structure of GB1 in a lattice. Dashed lines in (a,b) indicate 15N
sPREs calculated from structures: solution NMR structure of isolated
GB1 (PDB ID: 3gb1)58 in (a) and GB1 in a lattice (PDB ID: 2qmt)59
in (b). Each set of predicted sPREs were scaled by a global factor equal
to the ratio of the averages of the predicted sPREs and experimental
sPREs. Yellow lines in (d,e) represent intermolecular hydrogen bonds.
Residues for which data are not available either due to severe overlap,
missing peak, or insuﬃcient signal-to-noise are indicated in gray.
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formational change upon binding where the analysis becomes
much more involved).
Figure 3a,b shows experimental 15N R1 and R1ρ ΔsPREs for
GB1IgG. Both data sets reveal a rather similar pattern, which
diﬀers somewhat from ΔsPREs for GB1cryst. Overall, as
expected due to the shorter T1ρ times compared to T1 times,
the dynamics range of R1ρ ΔsPREs is smaller but still suﬃcient
to identify changes in the solvent accessibility caused by
complex formation. The fact that 15N R1ρ ΔsPREs appear to be
suﬃciently sensitive to characterize intermolecular contacts in
the GB1:IgG complex is fortunate because the acquisition of
high-quality R1ρ sPREs requires much shorter experimental
times compared to 15N R1 sPREs (from several days to
sometimes less than 24 h; see SI Table 11). The most
prominent feature arising from a comparison of 15N R1 and R1ρ
ΔsPREs in GB1IgG and 15N R1 ΔsPREs in GB1cryst is that β2 is
most protected in both assemblies. This is consistent with the
intermolecular hydrogen bonds between GB1 molecules in the
crystal and intermolecular hydrogen bonds to the Fab fragment
in the GB1:IgG complex. On the other hand, β3, which
interacts but does not form hydrogen bonds with the Fc
fragment in GB1IgG, is somewhat less protected than in the
crystals, where it forms intermolecular hydrogen bonds. Even
more interestingly, the N-terminal residues in the helix seem
similarly or better protected than β2 as a result of complex
formation. The above observations seem to be consistent with
creation of the interface between the helix and β3 of GB1 with
the Fc part of IgG.
To further investigate the protein−protein interfaces, we also
measured amide 1H solvent PREs. 1H sPREs of the GB1:IgG
complex were obtained from 1H R1 measurements (for
historical reasons using CuEDTA37 rather than Gd(DTPA-
BMA) and are presented in Figure 4b (data in SI Tables 6 and
7, comparison between predicted and experimental sPREs in SI
Figure 2). Reference experimental 1H sPREs for isolated GB1
in solution were taken from ref 66.
The overall trend in 1H ΔsPREs for the GB1:IgG complex is
similar to that in 15N ΔsPREs: again, as a result of the complex
formation, β2 is the most strongly protected; β3 is also
protected, but to a lesser extent, with Y45 exhibiting the
strongest level of protection. However, relative to the level of
Figure 2. Examples of linear ﬁts for sPREs for GB1 in complex with
IgG (GB1IgG) based on (a)
15N R1 and (b)
15N R1ρ relaxation rates. (c)
15N R1 sPREs and (d)
15N R1ρ sPREs for GB1 in the precipitated
complex with IgG.
Figure 3. 15N ΔsPREs for GB1IgG based on (a) R1 and (b) R1ρ
relaxation rates (gray bars). Lines indicate scaled ΔsPREs calculated
from back-predicted sPREs: GB1:IgG complex model (red continu-
ous), GB1:Fab complex model (dashed blue), and GB1:Fc complex
model (dotted gray). For the comparison, all back-predicted data sets
are scaled so that the average of the set is equal to the average of the
experimental data. The expected binding sites are highlighted: Fab
interface (residues 9−18) and Fc interface (residues 23−46).
Experimental 15N R1 (c) and R1ρ (d) ΔsPREs projected onto the
structural model of GB1 in a complex with IgG. Red indicates residues
with the largest changes in solvent accessibility upon binding and blue
the residues with the smallest changes upon binding. Residues for
which data are not available either due to severe overlap, missing peak,
or insuﬃcient signal-to-noise are indicated in gray.
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protection in β2, the residues in the helix seem to be very
slightly less protected than in 15N ΔsPREs.
The ΔsPREs back-calculated from models of GB1:IgG,
GB1:Fab, and GB1:Fc complexes are plotted as lines in Figure
3a,b and Figure 4c. A simple visual inspection is suﬃcient to see
that all three experimental ΔsPRE sets are more compatible
with the ΔsPREs back-calculated from a model of the GB1:IgG
complex, where both of the binding interfaces are occupied at
the same time. In all the cases, ΔsPREs calculated for GB1:Fab
grossly underestimate the level of protection for β3 and helix,
while ΔsPREs calculated for GB1:Fc grossly underestimate the
level of protection for β2 and overestimate the level of
protection for β3 acquired upon complex formation.
In order to obtain a more quantitative handle on how well
the diﬀerent structural models reproduce experimental data, we
have also performed a series of ﬁts of the experimental ΔsPREs
to ΔsPREs back-calculated from the diﬀerent models (note that
scaling of individual back-calculated sPREs is not required
before calculation of theoretical ΔsPREs), with a global scaling
factor as the only ﬁt parameter. Again, in such data the trends
are “cleaned up” from the eﬀects of GB1 conformation
simplifying quantiﬁcation of the contribution from intermo-
lecular interactions. In all the cases, data back-predicted from
the GB1:IgG complex, where both Fab and Fc interfaces are
occupied, give the lowest χ2, thus identifying it as the best from
the considered models of the interaction (see SI Table 12).
Upon closer inspection of the best-ﬁtting theoretical ΔsPRE
trends against the experimental ones, we identify one
particularly interesting feature where the two types of data
diﬀer. According to the experimental data, the protection due
to interactions between GB1 and IgG is similar for some
residues in β4 to that in β3, suggesting that either the ﬁrst
residues in β3 are less protected than expected or β4 is more
protected than expected. Diﬀerent levels of protection can be
explained by either a change of backbone conformation
between GB1free and GB1IgG, internal molecular motion, or
an additional interaction with IgG.
The Cα secondary chemical shifts for GB1 in complex with
IgG are very similar to the ones calculated for GB1 in solution
(see SI Figure 5, based on data from ref 7), with the exception
of L6, T11, L12, and K50 (Figure 5a). Consequently, subtle
changes in the backbone conformation are unlikely to explain
the changes in the solvent accessibility of β4. Internal molecular
motions could explain the diﬀerences in the ΔsPREs for
residues which exhibit large-amplitude backbone motions but
can be safely neglected for the rest of the residues, including
those in β4.8,61 This means that the observed deviations, if real
and not just experimental errors, must arise from changes in the
intermolecular interactions: additional interactions for the
increased protection and abolished interactions for the
decreased protection. Some changes in the solvent accessibility
might be expected if GB1 undergoes a small-amplitude
anisotropic overall motion in the complex, as we have suggested
based on the analysis of relaxation rates measured in the
complex.8 To investigate what eﬀect such motion would have
on the pattern of solvent accessibility, we generated a series of
conformers where the molecule of GB1 was rotated around the
axes of the motion by 7°, which corresponds to the
approximate amplitude of motion determined in our rather
simple analysis8 (the actual amplitude of motion may diﬀer
because in the absence of a dipolar order parameter relaxation
analysis is not very reliable53,61), followed by translating the
molecules, assuming that β2 hydrogen bonded to Fab is the
anchoring the point. The distribution of ΔsPREs calculated for
ﬁve generated conformers is illustrated in Figure 5d,e. In the
case of a proposed overall motion, the residues most immune
to changes in solvent accessibility as a result of this motion
would be located in β1, β4, and the C-terminal half of the helix.
Such a motion could, however, contribute to the discrepancies
observed for β3, V21, and loop 4 (D47 is the most inﬂuenced
of all residues).
Interestingly, we previously observed large chemical shift
perturbations (CSPs) for T53, V54, and L7 upon GB1:IgG
complex formation but were unable to completely explain their
origin (Figure 5a; L7 could potentially be explained by a small
backbone conformation change indicated by change in Cα
secondary chemical shift of L6Cα compared to solution data).
The presence of these CSPs and the elevated ΔsPREs suggest
that there might be an additional interaction between GB1 and
IgG, which involves β4 and is not observed in the complexes of
protein G domains with IgG fragments. Obviously, with the
available data, it is not possible for us to identify the region of
Figure 4. 1H R1 relaxation rates (a),
1H R1 sPREs (b), and
1H R1
ΔsPREs (c) for GB1IgG. Lines indicate scaled ΔsPREs calculated from
back-predicted sPREs: GB1:IgG complex model (red continuous),
GB1:Fab complex model (dashed blue), and GB1:Fc complex model
(dotted gray). The scaling procedure is the same as in Figure 3. The
expected binding sites are highlighted as in Figure 3. (d) 1H R1
ΔsPREs plotted onto the structure of GB1 in complex with full-length
IgG. Residues for which data are not available either due to severe
overlap, missing peak, or insuﬃcient signal-to-noise are indicated in
gray.
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IgG responsible for this potential additional interaction.
However, we can simulate the eﬀects of proximity of molecular
fragments to β4 on the ΔsPRE pattern in GB1IgG. We have
generated a model by translating one of the extended IgG loops
to make an intermolecular contact with β4 (Figure 5a). This
additional contact indeed reduces the anomalous ΔsPRE trend
for β4. In spite of complete arbitrariness of this model (the
exact structure of the fragment and its position are likely
diﬀerent), it is clear that the presence of a similar additional
interaction is consistent with the observed elevated ΔsPREs for
β4 and the large CSPs for residues 53 and 54. Interestingly, the
existence of such a contact would also help to explain why the
complex of GB1 with IgG gives such high-quality NMR spectra
that are atypical for a precipitate. With three interfaces, the local
environment of GB1 in the complex would be deﬁned almost
entirely by the speciﬁc interactions with IgG, leaving GB1
largely unaﬀected by any heterogeneity of the sample.
■ CONCLUSIONS
We introduced 1H and 15N solvent PREs as a general and
powerful tool for characterizing intermolecular interfaces in
large biomolecular complexes in the solid state. The proposed
methods can be applied over the majority of range of spinning
frequencies employed in biomolecular solid-state NMR:
moderate spinning frequencies (15N R1), intermediate spinning
frequencies (15N R1,
15N R1ρ), and fast spinning frequencies
(15N R1,
15N R1ρ,
1H R1), which allows to ﬁne-tune this
methodology to the speciﬁc requirements of diﬀerent systems
and available instrumentation. We demonstrate for 100% back-
exchanged protein in the presence of a fully protonated binding
partner that 1H−1H spin diﬀusion is suﬃciently slowed down at
100 kHz to allow the use of 1H R1 as a site-speciﬁc probe of
solvent accessibility. 1H R1 and
15N R1 are the most sensitive
probes, enabling accurate measurement of even small PREs. At
the same time, 15N R1ρ, even though less sensitive than
1H R1
and 15N R1 as sPRE probes, yields essentially the same picture,
with the added beneﬁt of overall shorter experiments, where
satisfactory signal-to-noise ratio can be achieved in a reasonable
amount of time, even for large biomolecular complexes
characterized by low sensitivity. We establish the beneﬁts of
comparing sPREs of isolated protein in solution to sPREs of
the protein in a complex in the solid state to identify reduced
solvent accessibility of regions involved in protein−protein
interactions.
Moreover, we demonstrate the utility of solid-state sPREs for
determining intermolecular interactions by applying it to
characterize intermolecular contacts in GB1 crystal and
protein−protein interfaces in GB1 in a complex with full-
length IgG. The experimental sPREs are in very good
agreement with predicted sPREs based on crystal structures.
All three sPRE probes15N R1, 15N R1ρ, and 1H R1yield a
highly consistent view of the GB1 interactions with IgG. Based
on the local deviations of ΔsPRE trends and CSPs, we suggest
that the extraordinary GB1:IgG binding interface might involve
three diﬀerent regions, painting a more complex picture than
what can be deduced from the structures of protein G with IgG
fragments, emphasizing the importance of using full-length
proteins in interaction studies if at all possible.
We envision the proposed approach to be widely applicable
for characterization of intermolecular interfaces in large protein
complexes and especially the ones that are not accessible to
other high-resolution techniques, as is the case for the
precipitated complex of GB1:IgG.
■ EXPERIMENTAL SECTION
Sample Preparation. Isotope-labeled GB1 2Q6I was expressed
using pGEV2 in BL21(DE3).67 [U-13C,15N]GB1 was puriﬁed from
cultures grown in M9 supplemented with [U-13C]glucose and
Figure 5. (a) Models of GB1:IgG complex with (A) only Fab and Fc
interface (cornﬂower blue) and (B) Fab, Fc and additional contact
with β4 (green). Residues with higher than average chemical shift
perturbations (CSPs) are indicated in orange.7 Previously unexplained
above average CSPs for residues 7, 53, and 54 are shown in red.7 Sites
with deviations of Cα secondary chemical shift compared to solution
are indicated in blue.7 (b,c) Experimental ΔsPREs vs ΔsPREs
predicted from GB1:IgG models in (a): model A (red line) and
model B (black dashed line). (d,e) Back-predicted ΔsPREs for GB1 in
complex with IgG assuming small amplitude overall anisotropic
motion of GB1 as suggested in ref 8. The lines in (d-e) represent a
range of ΔsPREs based on 5 generated conformers.
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15NH4Cl. [U-
2H,13C,15N]GB1 was expressed in M9 prepared in D2O
with deuterated [U-13C]glucose and 15NH4Cl. Cells were grown to an
OD600 > 1.0 in 2 L of LB medium for each liter of M9 and washed
once with PBS before resuspension in M9. Expression was induced
with 0.5 mM IPTG after 1 h incubation at 37 °C. After expression for
4 h at 37 °C, the cells were pelleted (4000g for 20 min at 16 °C) and
lysed by sonication in buﬀer (50 mM potassium phosphate; 200 mM
NaCl; 1 mg/mL lysozyme; pH 7.0). The lysate was then incubated at
75 °C for 10 min and cleared by centrifugation (12000g for 50 min).
After precipitation overnight with 80% ammonium sulfate, GB1 was
pelleted (15000g for 50 min), redissolved in buﬀer (50 mM potassium
phosphate; 200 mM NaCl; pH 7.0), and puriﬁed on a 16/600
Sephadex pg75 (GE Healthcare) gel ﬁltration column. Fractions
containing GB1 were collected, desalted, freeze-dried, and stored at
−20 °C.
Freeze-dried [U-2H,13C,15N]GB1 was dissolved in buﬀer (50 mM
sodium phosphate buﬀer pH 5.5) to obtain a protein concentration of
10 mg/mL and crystallized with the aid of 2:1 2-methyl-2,4-
pentanediol (MPD):isopropanol.68 Lyophilized IgG from human
serum was purchased from Sigma-Aldrich. GB1:IgG complex was
formed by mixing GB1 and IgG solutions in 2:1 molar ratio.7
Crystalline GB1 and precipitated GB1:IgG complex were packed into
NMR rotors using the following procedure: The crystals/precipitate
were spun down by centrifugation (1 min at 20000g using a benchtop
centrifuge) and resuspended in a small volume of the supernatant
containing 2% DSS and Gd(DTPA-BMA) at the desired concen-
tration. The 1.3 mm rotors were packed by centrifugation (20000g)
and the rotor caps sealed with a silicone-based glue to prevent leakage.
The smaller 0.81 mm rotors were ﬁlled manually using microspatulas.
The solution NMR sample was prepared in a 3 mm tube containing
200 μL of 1 mM [U-13C,15N]GB1 in 50 mM sodium phosphate, pH
5.5, 10% D2O, and 30 μM DSS.
Solution NMR. All solution NMR data were recorded at 298 K on
a 700 MHz Bruker Avance spectrometer equipped with a cryogenically
cooled probehead. 15N longitudinal relaxation rates (R1) were
measured with a 15N-HSQC-based standard Bruker pseudo-3D
(hsqct1etf3gpsi3d.2), with 8−10 points, using delays between 0.05
and 2.0 s (details are listed in SI Table 11). Spectral widths were 8400
Hz for 1H and 2700 Hz for 15N, and FIDs had 2048 and 256 points,
respectively. The recycle delay was 3.5 s. To obtain the sPREs, the
sample was titrated with Gd(DTPA-BMA) (Omniscan; stock 20 mM)
up to 2.5 mM (details in SI Table 11).
All spectra were processed in TopSpin 3.2 and CCPNMR,69 and
MatLab R2014a was used to analyze the relaxation data.
Solid-State NMR. Solid-state NMR spectra were recorded at 600
MHz Bruker Avance II+, 700 MHz Bruker Avance III HD, and 850
MHz Bruker Avance III spectrometers, using Bruker 1.3 mm triple-
resonance probes (at MAS frequencies of 50−60 kHz) or a volume-
optimized 0.81 mm double-resonance probe from Samoson laboratory
(for experiments at ∼100 kHz MAS). A Bruker BCU-X cooling unit
was used to regulate the internal sample temperature to 27 ± 1 °C
(measured from the chemical shift of water with respect to DSS). For
experiments recorded at 700 MHz 1H Larmor frequency, 10% D2O
was added to the sample buﬀer before packing the rotors, and
deuterium locking was used in the same way as in solution NMR.
15N−1H 2D correlation spectra were recorded using a proton-detected
heteronuclear correlation sequence. Double-quantum cross-polar-
ization (CP) contact times were between 0.5 and 1.5 ms and
individually optimized for each sample. Recycle delays between 0.2
and 2.5 s were used, depending on the amount of paramagnetic agent
and magnetic ﬁeld.
The maximum employed concentrations were chosen so that the
paramagnetic eﬀect does not lead to signiﬁcant line broadening and are
thus diﬀerent for diﬀerent samples; e.g., larger concentrations could be
used in GB1:IgG complex than in GB1 crystal to obtain similar line
widths.
In all solid-state experiments, hard pulses were applied at nutation
frequencies of 100 kHz (1.3 mm probe) or 125 kHz (0.81 mm probe)
for 1H and 83.3 kHz for 15N. WALTZ-16 decoupling at 10 kHz was
applied on protons during 15N evolution and on 15N channel during
direct 1H acquisition, while quadrature detection was achieved using
the States-TPPI method. Suppression of the water signal was achieved
by saturation, with 50−200 ms of slpTPPM 1H decoupling applied at
an amplitude of one-fourth of the MAS frequency38 or with 100−140
ms of MISSISSIPPI70 at an amplitude of half the MAS frequency on
resonance with the water signal.
R1 and R1ρ relaxation curves were sampled using 8−11 points for all
experiments except the diamagnetic 15N R1 in the complex, where only
2 points were used (SI Tables 10 and 11). Error estimates for the
integrals were achieved by duplicating one of the relaxation delays (R1)
or spin-lock lengths (R1ρ). A 10 kHz nutation frequency, measured by
a nutation experiment, was used for the spin-lock ﬁeld in the R1ρ
experiments.
All spectra were processed using TopSpin 3.2. GB1 resonances in
the complex with IgG were previously assigned on the basis of 3D
H(H)NH, CONH, CO(CA)NH, and CANH experiments.7 Peak
integrals were calculated in TopSpin 3.2. OriginPro 2016 and MatLab
R2014a were used to analyze the relaxation data.
Error Estimates. Peak integrals from TopSpin or peak volumes
from CCPNMR were exported to MatLab, where an exponential
function was used with the fminsearchbnd function to ﬁt the relaxation
data. Errors were calculated by Monte Carlo error estimations for R1
and R1ρ exponential ﬁts. A random number between 0 and 1 was
multiplied with the integral error and added to the recalculated
integrals or volumes. The ﬁtting was then repeated 2000 times with a
new random number between 0 and 1 generated each time. Values of
2 times the standard deviations of the R1 or R1ρ values received from
the ﬁts for each residue were used as errors. Errors for sPREs were
obtained in the same way but with linear ﬁts instead of exponential.
Error propagations for ΔPREs and PRE ratios were calculated using
standard formulas for error propagation.
PRE Predictions. Predicted sPRE data were computed using a
previously published grid-based approach.30,33,56 To this end, the
structural model was placed in a grid with equally spaced grid points.
The grid point to grid point distance was set to 0.2 Å, and the distance
between the outer atoms of the protein and the edges of the grid box
was set to 20 Å. Next, all grid points that were positioned within a
radius rclash around an atom of the protein were removed. The radius
rclash was set to rclash = rvdW,i + rGd, where rvdW,i is the van der Waals
radius of atom i and rGd is the radius of the paramagnetic compound
and was set to 3.5 Å. Next, the sPRE value of atom i of the protein was










where i is the index of the protein atom, the index j iterates over all
remaining grid points, and dij is the distance between the atom i and
grid point j.
Whenever two sPREs data sets of diﬀerent origin (e.g., theoretical
and experimental sPREs or experimental sPREs derived from diﬀerent
relaxation measurements) were compared directly, one of the data sets
is scaled by the ratio of the averages of the sPREs in each data set.
Only data points for residues present in both data sets were used to
calculate the average.
C++ code for calculating sPREs is available from the authors upon
request. For published structures that contained several models (like
solution NMR structure of GB1), the error of the sPRE prediction was
estimated using the standard deviation of the sPRE values of the
diﬀerent models. For calculation of sPREs for GB1free, a solution
structure (PDB ID: 3gb1;58 our construct is a T2Q mutant, but
comparison of sPREs calculated from isolated GB1 from several
diﬀerent solution and X-ray structures suggested that, in the case of
amide sPREs, diﬀerences are very small) was used, with the sPRE
reported as an average of the sPREs calculated for each conformer in
the bundle. For calculation of sPREs for GB1cryst, an X-ray structure
(PDB ID: 2qmt)59 was used, with a molecule in the middle of a 3×3
unit cell crystal lattice generated in Chimera71 using the Multiscale
Models tool. For sPREs for GB1:Fab complex, a model obtained by
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structural alignment of the X-ray structure of GB1 (PDB ID: 2qmt)
with GB3 in the X-ray structure of GB3:Fab (PDB ID: 1igc)72 was
used. For sPREs for GB1:Fc complex, a model obtained by structural
alignment of the X-ray structure of GB1 (PDB ID: 2qmt) with GB3 in
the X-ray structure of GB2:Fc (PDB ID: 1fcc)65 was used. For sPREs
for GB1:IgG complex, a model obtained by the alignment of the above
two complexes on GB1 (PDB IDs: 1igc and 1fcc) was used. Before
sPRE calculation, protons were added to the models using the default
tool in Chimera.
ΔsPREs were calculated as a diﬀerence between sPREs for isolated
molecules in solution and sPREs in the assembly. Both experimental
and theoretical ΔsPREs were calculated. sPREs were scaled by the
ratio of averages before calculating ΔsPREs to minimize bias from any
particular data set. Here we typically scaled up the sPREs from the
assembly to solution sPREs. Note that comparison of the two diﬀerent
theoretical sPRE data sets does not require scaling.
Fitting of the experimental ΔsPREs to ΔsPREs back-predicted from
various models was performed in Matlab. The best ﬁt was determined












where ΔsPREexp,i is experimental ΔsPRE for residue i, ΔsPREcalc,i is
ΔsPRE for residue i calculated from a given model, σΔsPREexp,i
2 is error
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